Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ADCT
ADCT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ADCT News
ADC Therapeutics Q4 2025 Earnings Call Insights
9h ago
seekingalpha
ADC Therapeutics Q4 Earnings Beat Expectations with Revenue Growth
11h ago
seekingalpha
ADC Therapeutics Reports 2025 Financial Results and Future Outlook
11h ago
PRnewswire
ADC Therapeutics to Announce Q4 Earnings on March 10
1d ago
seekingalpha
ADC Therapeutics to Host Q4 2025 Financial Results Call
Mar 03 2026
PRnewswire
ADC Therapeutics Announces Upcoming Investor Conference Schedule
Feb 24 2026
PRnewswire
ADC Therapeutics Amends Royalty Purchase Agreement with HealthCare Royalty
Feb 23 2026
PRnewswire
ADC Therapeutics Amends Royalty Purchase Agreement with HealthCare Royalty
Feb 23 2026
Newsfilter
ADC Therapeutics Grants Stock Options to New Employees
Feb 02 2026
PRnewswire
Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge
Jan 30 2026
PRnewswire
Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge
Jan 30 2026
Newsfilter
ADC Therapeutics Faces Securities Fraud Investigation, Stock Drops 14.13%
Jan 20 2026
Globenewswire
ADC Therapeutics Faces Securities Fraud Investigation as Stock Drops 14.13%
Jan 13 2026
Globenewswire
ADC Therapeutics Reports $73M Net Revenue for 2025 with Strong Cash Position
Jan 08 2026
Newsfilter
ADC Therapeutics Faces Securities Fraud Claims, Stock Drops 14.13%
Jan 08 2026
PRnewswire
ADC Therapeutics CEO Ameet Mallik to Present at J.P. Morgan Healthcare Conference on January 15, 2026
Jan 08 2026
PRnewswire
Show More News
